Grade: Research grade

Factory Location: Hangzhou

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe, Australasia,Asia,Middle East,Africa

Monthly Production Capacity: hundreds of grams

Packaging Information: 500mg,1g, 10g,50g 100g per package with icebag

Delivery Lead Time: In stock or 2-3 weeks

Sample Provided: yes

Payment Terms: T/T

Exendin (9-39), also known as Avexitide, is a 31-amino acid peptide that can selectively target and block GLP-1 receptors, normalize insulin secretion, and reduce postprandial hypoglycemia. It is a new treatment product of PBH (post-bariatric hypoglycemia). Avexitide's peptide synthesis process is similar to exenatide. Choosing appropriate raw materials and condensing agent system is the key to improving product yield.